ArticleLeukemia & lymphoma2021

Adverse events among chronic myelogenous leukemia patients treated with tyrosine kinase inhibitors: a real-world analysis of health plan enrollees.

Eric J Chow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.